SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001657312-23-000011
Filing Date
2023-05-09
Accepted
2023-05-09 08:47:27
Documents
46
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vrna-20230331.htm   iXBRL 10-Q 667637
2 EX-31.1 exhibit311q123.htm EX-31.1 8959
3 EX-31.2 exhibit312q123.htm EX-31.2 9054
4 EX-32.1 exhibit321q123.htm EX-32.1 5238
5 EX-32.2 exhibit322q123.htm EX-32.2 5395
11 GRAPHIC vrna-20230331_g1.jpg GRAPHIC 182762
  Complete submission text file 0001657312-23-000011.txt   3374449

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrna-20230331.xsd EX-101.SCH 20984
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrna-20230331_cal.xml EX-101.CAL 41994
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrna-20230331_def.xml EX-101.DEF 58485
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrna-20230331_lab.xml EX-101.LAB 293056
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrna-20230331_pre.xml EX-101.PRE 172262
40 EXTRACTED XBRL INSTANCE DOCUMENT vrna-20230331_htm.xml XML 323300
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38067 | Film No.: 23900165
SIC: 2834 Pharmaceutical Preparations